Medicare & Medicaid
There are increased monthly premiums, out-of-pocket costs and the elimination of some Medicare Advantage plans entirely.
CMS is expected to release the MA and Part D star ratings next week, ahead of the Oct. 15 Medicare open enrollment.
The deal with Pfizer will reduce the price of the company’s prescription drugs for Medicaid to Most Favored Nation pricing.
Growth in SNPs comprises nearly half of the total increase in MA enrollment since 2018.
The monthly premium will fall to $14, and benefit options will remain stable, CMS says.
The legislation is endorsed by numerous healthcare groups, including the American Hospital Association.
FDA will begin notifying physicians that pregnant women should avoid taking Tylenol during pregnancy unless absolutely necessary.
Half of the funding will be evenly distributed to all states and the other half will be awarded based on individual state metrics.
Study says use of the pain medicine during pregnancy was not associated with children’s risk of autism, ADHD or intellectual disability.
The agency says it’s aiming to ensure that Medicaid resources are directed appropriately.